Alkem Laboratories has incorporated its wholly owned subsidiary, Alkem Pharma Trading FZCO, in Dubai, UAE, under Regulation 30 of SEBI LODR Regulations. The pharmaceutical company received the Certificate of Formation from Dubai Airport Free Zone Authority, marking its strategic expansion into the Middle East region.

Subsidiary Financial Structure

The newly incorporated entity has been established with substantial financial backing from the parent company. Alkem Laboratories has subscribed to the complete authorized share capital of the Dubai subsidiary.

Strategic Business Objectives

Alkem Pharma Trading FZCO has been incorporated with a specific focus on expanding the company's export operations. The subsidiary aims to facilitate the export of Alkem Laboratories' products to African, South East Asian, and non-UAE markets, leveraging Dubai's strategic position as a global trading hub.

Regulatory Compliance

The incorporation has been disclosed under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. As a wholly owned subsidiary, Alkem Pharma Trading FZCO is classified as a related party of Alkem Laboratories Limited, with the parent company maintaining complete operational control.

The establishment of this Dubai-based subsidiary represents Alkem Laboratories' commitment to strengthening its international presence and expanding its pharmaceutical distribution network across emerging markets in Africa and South East Asia.

Alkem Laboratories has officially announced the launch of A to Z Daily, a comprehensive multivitamin supplement designed to provide holistic nutritional support for both body and mind. The company made this announcement through a press release filed under Regulation 30 with stock exchanges.

Product Specifications and Formulation

A to Z Daily represents a significant advancement in multivitamin supplementation, featuring a carefully crafted formulation of 26 essential vitamins, minerals, and select botanicals. The product is specifically designed for adults seeking everyday nutritional support beyond conventional multivitamins.

Key Nutritional Components

The supplement incorporates essential vitamins and minerals including Vitamin B complex, Vitamin D3, Vitamin C, Zinc, and Iron, specifically chosen for their roles in boosting energy levels, reducing fatigue, and improving immunity. Additionally, the formulation includes clinically-researched botanicals such as Ashwagandha, Bacopa monnieri (Brahmi), Panax ginseng, and the amino acid L-theanine.

Strategic Market Positioning

Dr. Vikas Gupta, Chief Executive Officer of Alkem, emphasized the product's unique positioning in addressing modern lifestyle challenges. "Our current lifestyles are placing sustained demands not just on physical health but also on mental well-being. A to Z Daily brings together essential ingredients to provide a balanced, everyday support for both body and mind. It is positioned not as a quick fix, but as a consistent, long-term approach for people seeking to manage everyday stress while improving overall vitality."

Unlike conventional multivitamins that primarily address nutritional deficiencies, A to Z Daily is designed as an everyday support supplement for maintaining physical energy while helping individuals stay mentally composed through daily pressures and routines. The product is intended for consistent, long-term use as part of a preventive wellness approach.

Company Profile and Market Presence

Alkem Laboratories Ltd. operates as the sixth largest pharmaceutical company in the Indian market, with dominant positions in anti-infectives, gastrointestinal, pain management drugs and supplements. The company maintains 18 state-of-the-art manufacturing facilities and research centers across India and the US, with meaningful presence in the US, Latin America, Australia and several Asian countries.